ZIOP - ZIOPHARM Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1466,3896,8614,332
Cost of Revenue34,13445,084157,791106,785
Gross Profit-33,988-38,695-150,930-102,453
Operating Expenses
Research Development----
Selling General and Administrative19,91814,79814,37717,647
Non Recurring----
Total Operating Expenses54,05259,882172,168124,432
Operating Income or Loss-53,906-53,493-165,307-120,100
Income from Continuing Operations
Total Other Income/Expenses Net789-8301012
Earnings Before Interest and Taxes-53,906-53,493-165,307-120,100
Interest Expense----
Income Before Tax-53,117-54,323-165,297-120,088
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-53,117-54,323-165,297-120,088
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-53,117-54,323-165,297-120,088
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares137,246-73,261-172,420-120,088